Bours V - Search Results

1

NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets.

Chariot A, Meuwis MA, Bonif M, Leonardi A, Merville MP, Gielen J, Piette J, Siebenlist U, Bours V. Chariot A, et al. Among authors: bours v. Curr Med Chem. 2003 Apr;10(7):593-602. doi: 10.2174/0929867033457926. Curr Med Chem. 2003. PMID: 12678791 Review.

2

Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3.

Viatour P, Legrand-Poels S, van Lint C, Warnier M, Merville MP, Gielen J, Piette J, Bours V, Chariot A. Viatour P, et al. Among authors: bours v. J Biol Chem. 2003 Nov 21;278(47):46541-8. doi: 10.1074/jbc.M306381200. Epub 2003 Sep 12. J Biol Chem. 2003. PMID: 12972430 Free article.

3

Phosphorylation of NF-kappaB and IkappaB proteins: implications in cancer and inflammation.

Viatour P, Merville MP, Bours V, Chariot A. Viatour P, et al. Among authors: bours v. Trends Biochem Sci. 2005 Jan;30(1):43-52. doi: 10.1016/j.tibs.2004.11.009. Trends Biochem Sci. 2005. PMID: 15653325 Free article. Review.

4

TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.

Bonif M, Meuwis MA, Close P, Benoit V, Heyninck K, Chapelle JP, Bours V, Merville MP, Piette J, Beyaert R, Chariot A. Bonif M, et al. Among authors: bours v. Biochem J. 2006 Mar 15;394(Pt 3):593-603. doi: 10.1042/BJ20051659. Biochem J. 2006. PMID: 16336209 Free PMC article.

5

IkappaB-alpha enhances transactivation by the HOXB7 homeodomain-containing protein.

Chariot A, Princen F, Gielen J, Merville MP, Franzoso G, Brown K, Siebenlist U, Bours V. Chariot A, et al. Among authors: bours v. J Biol Chem. 1999 Feb 26;274(9):5318-25. doi: 10.1074/jbc.274.9.5318. J Biol Chem. 1999. PMID: 10026139 Free article.

6

Regulation of NF-kappaB activity by I kappaB-related proteins in adenocarcinoma cells.

Dejardin E, Deregowski V, Chapelier M, Jacobs N, Gielen J, Merville MP, Bours V. Dejardin E, et al. Among authors: bours v. Oncogene. 1999 Apr 22;18(16):2567-77. doi: 10.1038/sj.onc.1202599. Oncogene. 1999. PMID: 10353600

7

NF-kappaB-dependent MnSOD expression protects adenocarcinoma cells from TNF-alpha-induced apoptosis.

Delhalle S, Deregowski V, Benoit V, Merville MP, Bours V. Delhalle S, et al. Among authors: bours v. Oncogene. 2002 May 30;21(24):3917-24. doi: 10.1038/sj.onc.1205489. Oncogene. 2002. PMID: 12032830

8

Identification of cytokine-induced nuclear factor-kappaB target genes in ovarian and breast cancer cells.

Deregowski V, Delhalle S, Benoit V, Bours V, Merville MP. Deregowski V, et al. Among authors: bours v. Biochem Pharmacol. 2002 Sep;64(5-6):873-81. doi: 10.1016/s0006-2952(02)01151-6. Biochem Pharmacol. 2002. PMID: 12213581

9

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells.

Bentires-Alj M, Barbu V, Fillet M, Chariot A, Relic B, Jacobs N, Gielen J, Merville MP, Bours V. Bentires-Alj M, et al. Among authors: bours v. Oncogene. 2003 Jan 9;22(1):90-7. doi: 10.1038/sj.onc.1206056. Oncogene. 2003. PMID: 12527911 Free article.

10

Mechanisms involved in exogenous C2- and C6-ceramide-induced cancer cell toxicity.

Fillet M, Bentires-Alj M, Deregowski V, Greimers R, Gielen J, Piette J, Bours V, Merville MP. Fillet M, et al. Among authors: bours v. Biochem Pharmacol. 2003 May 15;65(10):1633-42. doi: 10.1016/s0006-2952(03)00125-4. Biochem Pharmacol. 2003. PMID: 12754099 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

295 results

Search Page

Filters